WHO ICTRP trial
Preoperative sodium glucose cotransporter 2 inhibitors for prevention of…
NL-OMON53593 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON53593 |
|---|---|
| Public title | Preoperative sodium glucose cotransporter 2 inhibitors for prevention of postoperative acute kidney injury in cardiac surgery patients - a randomized, placebo-controlled, multi-centre, phase IV clinical trial |
| Scientific title | Preoperative sodium glucose cotransporter 2 inhibitors for prevention of postoperative acute kidney injury in cardiac surgery patients - a randomized, placebo-controlled, multi-centre, phase IV clinical trial - The MERCURI-2 trail |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 4 |
| Countries | Netherlands |
| Conditions | Cardiac Surgery-Associated Acute Kidney Injury; Kidney failure following cardiac surgery;10038430 |
| Interventions | Participants receive 10 mg dapagliflozin once daily or matching placebo starting 1 day prior to surgery and continued until two days postoperatively (four doses). |
| Registration date | Feb 14, 2023 |
| Target size | 784 |
| Secondary IDs | 2022-002453-25;NCT05590143;NL81190.018.22 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: